nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Citrulline—NOS3—systemic scleroderma	0.799	1	CbGaD
L-Citrulline—NOS1—myenteric nerve plexus—systemic scleroderma	0.02	0.146	CbGeAlD
L-Citrulline—NOS3—pulmonary artery—systemic scleroderma	0.0108	0.0788	CbGeAlD
L-Citrulline—NOS3—umbilical vein—systemic scleroderma	0.00712	0.0521	CbGeAlD
L-Citrulline—DDAH1—endothelium—systemic scleroderma	0.00664	0.0486	CbGeAlD
L-Citrulline—DDAH1—blood vessel—systemic scleroderma	0.00613	0.0448	CbGeAlD
L-Citrulline—PADI1—skin of body—systemic scleroderma	0.00602	0.0441	CbGeAlD
L-Citrulline—NOS1—artery—systemic scleroderma	0.00526	0.0384	CbGeAlD
L-Citrulline—PADI3—skin of body—systemic scleroderma	0.00503	0.0368	CbGeAlD
L-Citrulline—NOS1—endothelium—systemic scleroderma	0.00444	0.0325	CbGeAlD
L-Citrulline—NOS1—blood vessel—systemic scleroderma	0.00409	0.0299	CbGeAlD
L-Citrulline—NOS3—artery—systemic scleroderma	0.004	0.0292	CbGeAlD
L-Citrulline—NOS2—tendon—systemic scleroderma	0.00398	0.0291	CbGeAlD
L-Citrulline—NOS1—Rac1/Pak1/p38/MMP-2 pathway—TNIP1—systemic scleroderma	0.00396	0.0631	CbGpPWpGaD
L-Citrulline—PADI2—skin of body—systemic scleroderma	0.00351	0.0257	CbGeAlD
L-Citrulline—NOS3—endothelium—systemic scleroderma	0.00338	0.0247	CbGeAlD
L-Citrulline—DDAH1—connective tissue—systemic scleroderma	0.00314	0.023	CbGeAlD
L-Citrulline—PADI4—lung—systemic scleroderma	0.00314	0.023	CbGeAlD
L-Citrulline—NOS3—blood vessel—systemic scleroderma	0.00311	0.0228	CbGeAlD
L-Citrulline—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TNIP1—systemic scleroderma	0.00298	0.0476	CbGpPWpGaD
L-Citrulline—DDAH1—smooth muscle tissue—systemic scleroderma	0.00287	0.021	CbGeAlD
L-Citrulline—NOS1—Effects of Nitric Oxide—NOS3—systemic scleroderma	0.00274	0.0437	CbGpPWpGaD
L-Citrulline—PADI2—tendon—systemic scleroderma	0.00267	0.0195	CbGeAlD
L-Citrulline—NOS1—Spinal Cord Injury—AIF1—systemic scleroderma	0.00252	0.0401	CbGpPWpGaD
L-Citrulline—PADI2—lung—systemic scleroderma	0.00234	0.0172	CbGeAlD
L-Citrulline—DDAH1—digestive system—systemic scleroderma	0.00227	0.0166	CbGeAlD
L-Citrulline—DDAH2—tendon—systemic scleroderma	0.00224	0.0164	CbGeAlD
L-Citrulline—NOS1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—systemic scleroderma	0.00217	0.0346	CbGpPWpGaD
L-Citrulline—DDAH1—tendon—systemic scleroderma	0.00216	0.0158	CbGeAlD
L-Citrulline—NOS2—Effects of Nitric Oxide—NOS3—systemic scleroderma	0.00207	0.0329	CbGpPWpGaD
L-Citrulline—DDAH2—lung—systemic scleroderma	0.00196	0.0144	CbGeAlD
L-Citrulline—NOS1—smooth muscle tissue—systemic scleroderma	0.00192	0.014	CbGeAlD
L-Citrulline—NOS2—Spinal Cord Injury—AIF1—systemic scleroderma	0.0019	0.0303	CbGpPWpGaD
L-Citrulline—DDAH1—lung—systemic scleroderma	0.00189	0.0139	CbGeAlD
L-Citrulline—NOS3—ACE Inhibitor Pathway—ACE—systemic scleroderma	0.00189	0.0301	CbGpPWpGaD
L-Citrulline—NOS1—Serotonin Transporter Activity—IL1B—systemic scleroderma	0.00181	0.0288	CbGpPWpGaD
L-Citrulline—NOS2—Type II interferon signaling (IFNG)—IRF8—systemic scleroderma	0.00167	0.0266	CbGpPWpGaD
L-Citrulline—L-Arginine—NOS3—systemic scleroderma	0.00165	1	CrCbGaD
L-Citrulline—NOS3—connective tissue—systemic scleroderma	0.0016	0.0117	CbGeAlD
L-Citrulline—NOS1—digestive system—systemic scleroderma	0.00152	0.0111	CbGeAlD
L-Citrulline—NOS2—IL23-mediated signaling events—STAT4—systemic scleroderma	0.00147	0.0234	CbGpPWpGaD
L-Citrulline—ASS1—smooth muscle tissue—systemic scleroderma	0.00146	0.0107	CbGeAlD
L-Citrulline—NOS3—smooth muscle tissue—systemic scleroderma	0.00146	0.0107	CbGeAlD
L-Citrulline—ASS1—skin of body—systemic scleroderma	0.00145	0.0106	CbGeAlD
L-Citrulline—NOS1—tendon—systemic scleroderma	0.00144	0.0106	CbGeAlD
L-Citrulline—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—COL1A2—systemic scleroderma	0.00143	0.0228	CbGpPWpGaD
L-Citrulline—NOS1—lung—systemic scleroderma	0.00127	0.00926	CbGeAlD
L-Citrulline—NOS1—Spinal Cord Injury—TNFSF13—systemic scleroderma	0.00123	0.0196	CbGpPWpGaD
L-Citrulline—ASS1—digestive system—systemic scleroderma	0.00116	0.00846	CbGeAlD
L-Citrulline—NOS3—digestive system—systemic scleroderma	0.00115	0.00843	CbGeAlD
L-Citrulline—NOS1—Nitric oxide stimulates guanylate cyclase—NOS3—systemic scleroderma	0.00114	0.0181	CbGpPWpGaD
L-Citrulline—NOS2—IL12-mediated signaling events—CD247—systemic scleroderma	0.00113	0.0181	CbGpPWpGaD
L-Citrulline—ASS1—tendon—systemic scleroderma	0.0011	0.00805	CbGeAlD
L-Citrulline—NOS3—tendon—systemic scleroderma	0.0011	0.00802	CbGeAlD
L-Citrulline—NOS1—Spinal Cord Injury—SELP—systemic scleroderma	0.00109	0.0175	CbGpPWpGaD
L-Citrulline—NOS1—Spinal Cord Injury—RHOB—systemic scleroderma	0.00102	0.0163	CbGpPWpGaD
L-Citrulline—NOS2—IL12-mediated signaling events—STAT4—systemic scleroderma	0.000999	0.0159	CbGpPWpGaD
L-Citrulline—ASS1—lung—systemic scleroderma	0.000966	0.00706	CbGeAlD
L-Citrulline—NOS3—lung—systemic scleroderma	0.000963	0.00704	CbGeAlD
L-Citrulline—NOS2—Spinal Cord Injury—TNFSF13—systemic scleroderma	0.000927	0.0148	CbGpPWpGaD
L-Citrulline—NOS3—Thromboxane A2 receptor signaling—BLK—systemic scleroderma	0.000861	0.0137	CbGpPWpGaD
L-Citrulline—NOS1—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS3—systemic scleroderma	0.00086	0.0137	CbGpPWpGaD
L-Citrulline—NOS2—Nitric oxide stimulates guanylate cyclase—NOS3—systemic scleroderma	0.000858	0.0137	CbGpPWpGaD
L-Citrulline—NOS3—Endothelin Pathways—EDN1—systemic scleroderma	0.000847	0.0135	CbGpPWpGaD
L-Citrulline—NOS2—Spinal Cord Injury—SELP—systemic scleroderma	0.000826	0.0132	CbGpPWpGaD
L-Citrulline—NOS2—Spinal Cord Injury—RHOB—systemic scleroderma	0.000771	0.0123	CbGpPWpGaD
L-Citrulline—NOS1—Monoamine Transport—IL1B—systemic scleroderma	0.000769	0.0123	CbGpPWpGaD
L-Citrulline—NOS2—Circadian rythm related genes—TOP1—systemic scleroderma	0.00073	0.0116	CbGpPWpGaD
L-Citrulline—NOS2—IL23-mediated signaling events—CCL2—systemic scleroderma	0.000681	0.0109	CbGpPWpGaD
L-Citrulline—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP1—systemic scleroderma	0.00065	0.0104	CbGpPWpGaD
L-Citrulline—NOS2—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS3—systemic scleroderma	0.000649	0.0104	CbGpPWpGaD
L-Citrulline—NOS2—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	0.000627	0.00999	CbGpPWpGaD
L-Citrulline—NOS3—ACE Inhibitor Pathway—TGFB1—systemic scleroderma	0.00058	0.00925	CbGpPWpGaD
L-Citrulline—NOS3—Angiogenesis—MMP9—systemic scleroderma	0.000534	0.00852	CbGpPWpGaD
L-Citrulline—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—systemic scleroderma	0.000528	0.00843	CbGpPWpGaD
L-Citrulline—NOS1—Spinal Cord Injury—IL1A—systemic scleroderma	0.000519	0.00828	CbGpPWpGaD
L-Citrulline—NOS2—IL23-mediated signaling events—IL1B—systemic scleroderma	0.000516	0.00823	CbGpPWpGaD
L-Citrulline—NOS2—Type II interferon signaling (IFNG)—IL1B—systemic scleroderma	0.000516	0.00823	CbGpPWpGaD
L-Citrulline—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—systemic scleroderma	0.000503	0.00802	CbGpPWpGaD
L-Citrulline—NOS3—Plasma membrane estrogen receptor signaling—MMP2—systemic scleroderma	0.000463	0.00739	CbGpPWpGaD
L-Citrulline—NOS2—ATF-2 transcription factor network—MMP2—systemic scleroderma	0.000446	0.00711	CbGpPWpGaD
L-Citrulline—NOS1—Platelet homeostasis—NOS3—systemic scleroderma	0.000443	0.00706	CbGpPWpGaD
L-Citrulline—NOS3—EGF/EGFR Signaling Pathway—CSK—systemic scleroderma	0.000423	0.00675	CbGpPWpGaD
L-Citrulline—NOS2—AGE/RAGE pathway—MMP2—systemic scleroderma	0.000408	0.0065	CbGpPWpGaD
L-Citrulline—NOS3—Angiopoietin receptor Tie2-mediated signaling—MMP2—systemic scleroderma	0.000395	0.0063	CbGpPWpGaD
L-Citrulline—NOS2—Spinal Cord Injury—IL1A—systemic scleroderma	0.000391	0.00624	CbGpPWpGaD
L-Citrulline—NOS2—AGE/RAGE pathway—NOS3—systemic scleroderma	0.000382	0.00609	CbGpPWpGaD
L-Citrulline—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—systemic scleroderma	0.000378	0.00603	CbGpPWpGaD
L-Citrulline—NOS1—Alzheimers Disease—IL1B—systemic scleroderma	0.000373	0.00595	CbGpPWpGaD
L-Citrulline—NOS1—Spinal Cord Injury—CCL2—systemic scleroderma	0.000357	0.00569	CbGpPWpGaD
L-Citrulline—NOS2—IL12-mediated signaling events—IL1B—systemic scleroderma	0.000351	0.00559	CbGpPWpGaD
L-Citrulline—NOS3—Plasma membrane estrogen receptor signaling—MMP9—systemic scleroderma	0.000348	0.00555	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—SELP—systemic scleroderma	0.000342	0.00545	CbGpPWpGaD
L-Citrulline—NOS2—Platelet homeostasis—NOS3—systemic scleroderma	0.000334	0.00533	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—RHOB—systemic scleroderma	0.000319	0.00509	CbGpPWpGaD
L-Citrulline—NOS3—AGE/RAGE pathway—MMP2—systemic scleroderma	0.000316	0.00505	CbGpPWpGaD
L-Citrulline—NOS2—AGE/RAGE pathway—MMP9—systemic scleroderma	0.000306	0.00489	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—CSK—systemic scleroderma	0.00029	0.00463	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—ITGAM—systemic scleroderma	0.000273	0.00436	CbGpPWpGaD
L-Citrulline—NOS1—Spinal Cord Injury—IL1B—systemic scleroderma	0.000271	0.00432	CbGpPWpGaD
L-Citrulline—NOS2—Spinal Cord Injury—CCL2—systemic scleroderma	0.000269	0.00429	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—SELP—systemic scleroderma	0.000258	0.00411	CbGpPWpGaD
L-Citrulline—NOS1—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	0.000256	0.00408	CbGpPWpGaD
L-Citrulline—NOS1—Spinal Cord Injury—MMP9—systemic scleroderma	0.000255	0.00407	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—RHOB—systemic scleroderma	0.000241	0.00384	CbGpPWpGaD
L-Citrulline—NOS3—AGE/RAGE pathway—MMP9—systemic scleroderma	0.000238	0.00379	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—HSPG2—systemic scleroderma	0.000237	0.00378	CbGpPWpGaD
L-Citrulline—NOS3—Leptin signaling pathway—IL1B—systemic scleroderma	0.000228	0.00363	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—CSK—systemic scleroderma	0.000219	0.00349	CbGpPWpGaD
L-Citrulline—NOS1—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	0.000218	0.00347	CbGpPWpGaD
L-Citrulline—NOS1—Spinal Cord Injury—TGFB1—systemic scleroderma	0.00021	0.00335	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—ITGAM—systemic scleroderma	0.000206	0.00329	CbGpPWpGaD
L-Citrulline—NOS2—Spinal Cord Injury—IL1B—systemic scleroderma	0.000204	0.00326	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—SELP—systemic scleroderma	0.0002	0.00319	CbGpPWpGaD
L-Citrulline—NOS1—Disease—SMAD7—systemic scleroderma	0.0002	0.00318	CbGpPWpGaD
L-Citrulline—NOS2—Spinal Cord Injury—MMP9—systemic scleroderma	0.000192	0.00307	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—RHOB—systemic scleroderma	0.000187	0.00298	CbGpPWpGaD
L-Citrulline—NOS1—Disease—TGFBI—systemic scleroderma	0.000183	0.00291	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—CTGF—systemic scleroderma	0.000179	0.00286	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—CSK—systemic scleroderma	0.00017	0.00271	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—HSPG2—systemic scleroderma	0.000164	0.00262	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—ITGAM—systemic scleroderma	0.00016	0.00255	CbGpPWpGaD
L-Citrulline—NOS2—Spinal Cord Injury—TGFB1—systemic scleroderma	0.000159	0.00253	CbGpPWpGaD
L-Citrulline—NOS2—Disease—SMAD7—systemic scleroderma	0.000151	0.0024	CbGpPWpGaD
L-Citrulline—NOS3—Corticotropin-releasing hormone—TGFB1—systemic scleroderma	0.00015	0.0024	CbGpPWpGaD
L-Citrulline—NOS1—Disease—HSPG2—systemic scleroderma	0.000146	0.00232	CbGpPWpGaD
L-Citrulline—NOS1—Disease—CSK—systemic scleroderma	0.000141	0.00224	CbGpPWpGaD
L-Citrulline—NOS2—Disease—TGFBI—systemic scleroderma	0.000138	0.0022	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—MMP1—systemic scleroderma	0.000137	0.00218	CbGpPWpGaD
L-Citrulline—NOS1—Disease—CD247—systemic scleroderma	0.000132	0.00211	CbGpPWpGaD
L-Citrulline—NOS3—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	0.000127	0.00203	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—CTGF—systemic scleroderma	0.000124	0.00198	CbGpPWpGaD
L-Citrulline—NOS3—Disease—SMAD7—systemic scleroderma	0.000117	0.00186	CbGpPWpGaD
L-Citrulline—NOS2—Disease—HSPG2—systemic scleroderma	0.00011	0.00175	CbGpPWpGaD
L-Citrulline—NOS3—Disease—TGFBI—systemic scleroderma	0.000107	0.00171	CbGpPWpGaD
L-Citrulline—NOS2—Disease—CSK—systemic scleroderma	0.000106	0.00169	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—MMP1—systemic scleroderma	0.000103	0.00165	CbGpPWpGaD
L-Citrulline—NOS2—Disease—CD247—systemic scleroderma	9.97e-05	0.00159	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—NOS3—systemic scleroderma	9.92e-05	0.00158	CbGpPWpGaD
L-Citrulline—NOS3—Disease—HSPG2—systemic scleroderma	8.53e-05	0.00136	CbGpPWpGaD
L-Citrulline—NOS3—Disease—CSK—systemic scleroderma	8.24e-05	0.00131	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—SMAD7—systemic scleroderma	8.19e-05	0.00131	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—MMP1—systemic scleroderma	8.02e-05	0.00128	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—NOS3—systemic scleroderma	7.81e-05	0.00125	CbGpPWpGaD
L-Citrulline—NOS3—Disease—CD247—systemic scleroderma	7.74e-05	0.00124	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—NOS3—systemic scleroderma	7.48e-05	0.00119	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—HSPG2—systemic scleroderma	7.14e-05	0.00114	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—TGFB1—systemic scleroderma	6.56e-05	0.00105	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—RHOB—systemic scleroderma	6.33e-05	0.00101	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—HSPG2—systemic scleroderma	5.97e-05	0.000952	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CSK—systemic scleroderma	5.77e-05	0.00092	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CTGF—systemic scleroderma	5.41e-05	0.000863	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—NOS3—systemic scleroderma	5.41e-05	0.000863	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—TGFB1—systemic scleroderma	4.95e-05	0.000789	CbGpPWpGaD
L-Citrulline—NOS1—Disease—NOS3—systemic scleroderma	4.8e-05	0.000766	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—TGFB1—systemic scleroderma	3.84e-05	0.000613	CbGpPWpGaD
L-Citrulline—NOS2—Disease—NOS3—systemic scleroderma	3.62e-05	0.000578	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—EDN1—systemic scleroderma	3.23e-05	0.000516	CbGpPWpGaD
L-Citrulline—NOS1—Disease—TGFB1—systemic scleroderma	3.18e-05	0.000507	CbGpPWpGaD
L-Citrulline—NOS2—Disease—TGFB1—systemic scleroderma	2.4e-05	0.000382	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CCL2—systemic scleroderma	2.21e-05	0.000353	CbGpPWpGaD
L-Citrulline—NOS3—Disease—TGFB1—systemic scleroderma	1.86e-05	0.000297	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—MMP9—systemic scleroderma	1.58e-05	0.000252	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—TGFB1—systemic scleroderma	1.3e-05	0.000208	CbGpPWpGaD
